Connecticut Attorney General Richard Blumenthal sued seven drugmakers for allegedly inflating the pharmaceutical costs incurred by the state Medicaid program and its beneficiaries. Similar lawsuits have been filed by California, New York and Texas. The suits accuse drug companies of overstating the average wholesale price for their products to increase providers' reimbursement and induce them to prescribe the companies' drugs more often. Blumenthal is seeking $15 million in actual damages, plus civil penalties, for alleged overcharges involving drugs used to treat asthma, cancer and respiratory ailments. The companies are Aventis, Dey, GlaxoSmithKline, Pharmacia Corp., Roxanne Laboratories, Schering-Plough Corp. and Warrick Pharmaceuticals. -- by Cinda Becker
Conn. goes after drugmakers for overstating price
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.